Literature DB >> 26803207

Opiate receptor blockade on human granulosa cells inhibits VEGF release.

Fabian Lunger1, Anni P Vehmas2, Barbara G Fürnrohr3, Sieghart Sopper4, Ludwig Wildt1, Beata Seeber5.   

Abstract

The objectives of this study were to determine whether the main opioid receptor (OPRM1) is present on human granulosa cells and if exogenous opiates and their antagonists can influence granulosa cell vascular endothelial growth factor (VEGF) production via OPRM1. Granulosa cells were isolated from women undergoing oocyte retrieval for IVF. Complementary to the primary cells, experiments were conducted using COV434, a well-characterized human granulosa cell line. Identification and localization of opiate receptor subtypes was carried out using Western blot and flow cytometry. The effect of opiate antagonist on granulosa cell VEGF secretion was assessed by enzyme-linked immunosorbent assay. For the first time, the presence of OPRM1 on human granulosa cells is reported. Blocking of opiate signalling using naloxone, a specific OPRM1 antagonist, significantly reduced granulosa cell-derived VEGF levels in both COV434 and granulosa-luteal cells (P < 0.01). The presence of opiate receptors and opiate signalling in granulosa cells suggest a possible role in VEGF production. Targeting this signalling pathway could prove promising as a new clinical option in the prevention and treatment of ovarian hyperstimulation syndrome.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  OHSS; OPRM1; VEGF; granulosa cells; naloxone; opioid receptor

Mesh:

Substances:

Year:  2016        PMID: 26803207     DOI: 10.1016/j.rbmo.2015.12.006

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  3 in total

1.  Analysis of the Immunoexpression of Opioid Receptors and their Correlation with Markers of Angiogenesis, Cell Proliferation and Apoptosis in Breast Cancer.

Authors:  Alceu Machado De Sousa; Thinali Sousa Dantas; Paulo Goberlânio De Barros Silva; Conceição Da Silva Martins; Gildenio Estevam Freire; Howard Lopes Ribeiro Junior; Gerly Anne De Castro Brito; Karuza Maria Alves Pereira; Renata Ferreira De Carvalho Leitão
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

2.  Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study.

Authors:  Khalid M Salama; Hesham M Abo Ragab; Mohammed F El Sherbiny; Ali A Morsi; Ibrahim I Souidan
Journal:  BMC Womens Health       Date:  2017-11-13       Impact factor: 2.809

3.  Beta endorphin in serum and follicular fluid of PCOS- and non-PCOS women.

Authors:  Nikolai Jaschke; Fabian Lunger; Ludwig Wildt; Beata Seeber
Journal:  Arch Gynecol Obstet       Date:  2018-05-28       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.